Neutral impactCompany
Sun Pharma Share Price Live Updates: Sun Pharma's six-month beta reflects stability
Economic Times 1 hr ago·17 Aug 2026, 2:41 am
Sun Pharma has reported a beta of 0.66 for the past six months, indicating that its stock price has been less volatile than the broader market. This metric measures the stock's sensitivity to market movements, with a beta below 1 suggesting that the shares tend to move less dramatically than the index. For investors, this figure highlights the company's relative stability, potentially offering a safer haven during periods of high market turbulence.
This stability is significant as it suggests that Sun Pharma's performance is driven more by its own fundamentals rather than general market sentiment. While a low beta does not guarantee future returns, it provides a measure of risk management for those seeking to diversify their portfolios. Investors should continue to monitor the company's operational progress and sector trends to gauge its long-term trajectory.
Key takeaways
- Category: Company.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
